Riskpilot← Back to searchSign inGet full accessLIFE TECHNOLOGIES AS
ASActiveOrg 941218555Ullernchausséen 52, 0379 OsloManufacture of other chemical products n.e.c. · NACE 2059Est. 1986272 employees
Revenue 2024
NOK 2,5B
+18% vs 2023
EBITDA margin
59.4%
+28% vs 2023
Equity ratio
30.2%
Financial strength
Net profit 2024
NOK 1,2B
+25% vs 2023
| Revenue | NOK 2,5B | +18% |
| EBITDA | NOK 1,5B | +28% |
| Net profit | NOK 1,2B | +25% |
| Total assets | NOK 3,1B | -22% |
| Equity | NOK 920,6M | -9% |
| Employees | 272 | — |
Legal name
LIFE TECHNOLOGIES AS
Org number
941218555
Legal form
Aksjeselskap
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
6. februar 1986
Share capital
NOK 34 546 000
Employees
272 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikle, produsere og markedsføre systemer for bearbeidelse og analyse av biologisk materiale for anvendelse i forskning, diagnostikk og terapi, samt annen beslektet virksomhet og deltakelse i andre selskaper i tilknytning til dette.
Address
Ullernchausséen 52, 0379 Oslo
Phone
+4722061000
Email
customerservice@lifetechindia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 341 126 | 468 624 | 556 481 | 759 449 | 814 744 | 1 142 021 | 1 097 920 | 1 119 573 | 1 262 592 | 1 676 920 | 1 744 756 | 1 902 308 | 2 148 602 | 2 545 398 |
| Staff expenses | −127 669 | −120 249 | −141 183 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 140 752 | 209 301 | 268 023 | 460 454 | 427 344 | 778 277 | 687 971 | 588 175 | 636 872 | 895 410 | 937 493 | 1 030 587 | 1 185 566 | 1 511 837 |
| Depreciation & amort. | −29 484 | −30 506 | −15 563 | −13 122 | −20 229 | −14 184 | −14 937 | −13 986 | −14 385 | −12 806 | −18 310 | −19 651 | −0 | −37 552 |
| EBIT | 111 268 | 178 795 | 252 460 | 447 332 | 407 115 | 764 093 | 673 034 | 574 189 | 622 487 | 882 604 | 919 183 | 1 010 936 | 1 185 566 | 1 474 285 |
| Net financials | 230 534 | −14 825 | 2 225 | −2 696 | 9 840 | −7 053 | −6 249 | 33 700 | 3 216 | −3 198 | 4 478 | 35 142 | 78 236 | 134 396 |
| Profit before tax | 341 802 | 163 970 | 254 685 | 444 636 | 416 955 | 757 040 | 666 785 | 607 889 | 625 703 | 879 406 | 923 661 | 1 046 078 | 1 263 802 | 1 608 681 |
| Tax | 41 771 | 47 137 | 71 869 | −0 | −0 | 188 962 | 159 447 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 300 031 | 116 833 | 182 816 | 322 434 | 302 310 | 568 078 | 507 338 | 467 082 | 478 557 | 685 012 | 698 562 | 814 482 | 982 874 | 1 233 327 |
| Item | 2008 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 500 835 | 804 344 | 489 566 | 1 368 037 | 1 852 569 | 2 571 446 | 3 293 416 | 2 348 567 | 1 696 793 | 2 622 536 | 3 612 519 | 2 639 332 | 3 921 630 | 3 051 035 |
| Equity | 439 414 | 646 368 | 290 213 | 293 588 | 264 607 | 258 507 | 267 724 | 299 420 | 226 360 | 1 508 854 | 2 369 439 | 1 053 126 | 1 010 828 | 920 645 |
| Long-term debt | 6 301 | 9 064 | 9 318 | 11 440 | 2 426 | 0 | 0 | 1 234 | 0 | 0 | 7 808 | 2 041 | 9 284 | 5 585 |
| Short-term debt | 41 802 | 148 351 | 189 738 | 1 062 947 | 1 585 536 | 2 312 939 | 3 025 692 | 2 047 913 | 1 470 433 | 1 113 682 | 1 235 272 | 1 584 166 | 2 901 518 | 2 124 804 |
| Total debt | 48 103 | 157 415 | 199 056 | 1 074 387 | 1 587 962 | 2 312 939 | 3 025 692 | 2 049 147 | 1 470 433 | 1 113 682 | 1 243 080 | 1 586 207 | 2 910 802 | 2 130 389 |
EBITDA margin
59.4%
This company
15.8%
Market median
+276% vs market
20082024
Equity ratio
30.2%
This company
38.2%
Market median
+21% vs market
20082024
Return on equity
134.0%
This company
18.4%
Market median
+628% vs market
20082024
Net profit margin
48.5%
This company
8.1%
Market median
+499% vs market
20082024
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20082024
Debt / equity
2.31×
This company
0.62×
Market median
-273% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IO Deputy Member | Deputy Member | 2026 | — | — |
MT Deputy Member | Deputy Member | 2026 | — | — |
AK Deputy Member | Deputy Member | 2022 | — | — |
HP Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
TØ Deputy Member | Deputy Member | 2022 | — | — |
TN Deputy Member | Deputy Member | 2026 | — | — |
AH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
LE Deputy Member | Deputy Member | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Life Technologies Europe Bv | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LIFE TECHNOLOGIES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingrid Oddhild Finseth Manger | Deputy Member | 0 companies |
| Maren Teresa Johansen | Deputy Member | 0 companies |
| Anette Kullmann | Deputy Member | 0 companies |
| Hanne-Sofie Pedersen | Chief Executive Officer | 0 companies |
| Therese Østereng | Deputy Member | 0 companies |
| Thomas Nordbø Solvi | Deputy Member | 0 companies |
| Anne Haugland | Chief Executive Officer | 0 companies |
| Lars Emil Andersen | Deputy Member | 0 companies |
| Petrus Thomas Adrianus Van Der Zande | Chairman | 0 companies |
| Malene Gaulin | Board of Directors | 0 companies |
| Terje Kremmervik Hekkelstrand | Board of Directors | 0 companies |
| Malin Rigmor Karlsson | Board of Directors | 0 companies |
| Geir Hetland | Board of Directors | 0 companies |
| Lynn Gray | Board of Directors | 0 companies |
| Kari Hafskjær | Board of Directors | 0 companies |
| Siobhan Lisa Anton Moroney | Board of Directors | 0 companies |